Inhaled misoprostol blocks guinea pig antigen-induced bronchoconstriction and airway inflammation

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 2, 1996, Pages 295-299

  Smith, Walter C ^a   Thompson, Janice M ^b   Kowalski, Donna L ^b   Mckearn, John P ^b  

^a PFIZER INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY 16 HYDROXY 16 METHYLPROSTAGLANDIN E1; INTERLEUKIN 5; MISOPROSTOL; PROSTAGLANDIN D2; PROSTAGLANDIN F2 ALPHA; THROMBOXANE; UNCLASSIFIED DRUG;

AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; ASTHMA; BRONCHOSPASM; GUINEA PIG; LUNG LAVAGE; MALE; NONHUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; STATISTICAL ANALYSIS;

EID: 0029758448     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.2.8756797     Document Type: Article

References (29)

1. 2. Adv. Prostaglandin Thromboxane Res. 1:461-475.
2. 2α on the airway resistance of healthy and asthmatic man. Clin. Sci. Mol. Med. 48:421-430.
3. Chung, K. F. Asthma as an Inflammatory Disease. 1990. Marcel Dekker, New York. 159-183.
4. 2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma. Thorax 46:633-637.
5. O'Byrne, P. M., and G. L. Jones. 1986. The effect of indomethacin on exercise-induced bronchoconstriction and refractoriness after exercise. Am. Rev. Respir. Dis. 134:69-72.
6. Manning, P. J., R. M. Watson, and P. M. O'Byrne. 1993. Exercise-induced refractoriness in asthmatic subjects involves leukotriene and prostaglandin interdependent mechanisms. Am. Rev. Respir. Dis. 148:950-954.
7. 2 on allergen-induced asthma. Am. Rev. Respir. Dis. 148:87-90.
8. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F.-B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
9. Kay, A. B. 1991. Asthma and inflammation. J. Allergy Clin. Immunol. 87:893-910.
10. Collins, P. W. 1990. Misoprostol: discovery, development and clinical applications. Med. Res. Rev. 10:149-172.
11. Tsai, B. S., L. K. Kessler, P. W. Collins, S. W. Kramer, and R. F. Bauer. 1987. Antisecretory activity of misoprostol, its racemates, stereoisomers and metabolites in isolated parietal cells. Prostaglandins 33 (Suppl.):30-39.
12. Karim, A. 1987. Antiulcer prostaglandin misoprostol: single and multiple dose pharmacokinetic profile. Prostaglandins 33(Suppl.):40-50.
13. Bauer, R. F. 1985. Misoprostol preclinical pharmacology. Dig. Dis. Sci. 30:118S-125S.
14. Schumacher, J. H., A. O'Garra, B. Shrader, A. van Kimmenade, M. W. Bond, T. R. Mosmann, and R. T. Coffman. 1988. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent assays. J. Immunol. 141:1576-1581.
15. Daffonchio, L., I. W. Lees, A. N. Payne, and B. J. R. Whittle. 1987. Pharmacological modulation of bronchial anaphylaxis induced by aerosol challenge in anaesthetized guinea-pigs. Br. J. Pharmacol. 91: 701-708.
16. Payne, A. M., L. G. Garland, I. W. Lees, and J. A. Salmon. 1988. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on bronchial anaphylaxis in anaesthetized guinea-pigs. Br. J. Pharmacol. 94:540-546.
17. Dunnett, C. W., and A. C. Tamhane. 1991. Step-down multiple tests for comparing treatments with a control in unbalanced one-way layouts. Stat. Med. 10:939-947.
18. Ishida, K., L. J. Kelley, R. J. Thomson, L. L. Beattie, and R. R. Schellenberg. 1989. Repeated antigen challenge induces airway hyperresponsiveness with tissue eosinophilia in guinea pigs. J. Appl. Physiol. 67: 1133-1139.
19. 2 on exercise-induced bronchoconstriction in asthmatic subjects. Am. J. Respir. Crit. Care Med. 149:1138-1141.
20. Sanderson, C. J. 1992. Interleukin-5, eosinophils, and disease. Blood 79:3101-3109.
21. Corrigan, C. J., and A. B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13:501-507.
22. Van Oosterhout, A. J. M., A. R. C. Ladenius, H. F. J. Savelkoul, I. Van Ark, K. C. Delsman, and F. P. Nijkamp. 1993. Effects of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147:548-552.
23. 2: apparent correlation with in vivo modulation of mediator release. Proc. Natl. Acad. Sci. U.S.A. 85:2315-2319.
24. Hogaboam, C. M., E. Y. Bissonette, B. C. Chin, A. D. Befus, and J. L. Wallace. 1993. Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology 104:122-129.
25. Van Oosterhaut, A. J. M., and F. P. Nijkamp. 1993. Role of cytokines in bronchial hyperresponsiveness. Pulm. Pharmacol. 6:225-236.
26. Widomski, D. L., R. E. Walsh, D. A. Baron, M. I. Hidvegi, D. J. Fretland, P. W. Collins, and T. S. Gaginella. 1991. Effects of the prostaglandin analogue misoprostol on inflammatory mediator release by human monocytes. Agents Actions 34:30-31.
27. Alam, R., A. Dejarnatt, S. Stafford, P. A. Forsythe, D. Kumar, and J. A. Grant. 1993. Selective inhibition of the cutaneous late but not immediate allergic response to antigens by misoprostol, a PGE analog. Am. Rev. Respir. Dis. 148:1066-1070.
28. 1 on airway hyperresponsiveness. Pulm. Pharmacol. 2:121-124.
29. 1 analog in the treatment of glucocorticoid-dependent adult asthmatics. 142nd Annual Meeting of the American Pharmaceutical Association Annual Meeting and Exposition, Orlando, FL, March 1995.